Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Subcutaneous pembrolizumab is a viable treatment option for mNSCLC

Prof Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain

Subcutaneous pembrolizumab is a viable treatment option for mNSCLC ( Prof Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain )

Recognising Excellence: The Vanessa Moss Prize - A Step Towards Equity in...

Recognising Excellence: The Vanessa Moss Prize - A Step Towards Equity in Global Health ( )

Addition of radical prostatectomy to systemic treatment improves survival in...

Dr Fabian Falkenbach - Martini-Klinik Prostate Cancer Center, Hamburg, Germany

Addition of radical prostatectomy to systemic treatment improves survival in oligometastatic prostate cancer ( Dr Fabian Falkenbach - Martini-Klinik Prostate Cancer Center, Hamburg, Germany )

NeuroSAFE-guided RARP improves surgical precision for patients with localised...

Prof Greg Shaw - University College Hospital, London, UK

NeuroSAFE-guided RARP improves surgical precision for patients with localised prostate cancer ( Prof Greg Shaw - University College Hospital, London, UK )

The added value of integrative medicine

Dr Marta Capelan, Dr Beth DuPree and Rosa Olmos

The added value of integrative medicine ( Dr Marta Capelan, Dr Beth DuPree and Rosa Olmos )

Urine test could reduce post-op scans for kidney cancer by half

Dr Saeed Dabestani - Lund university, Lund, Sweden

Urine test could reduce post-op scans for kidney cancer by half ( Dr Saeed Dabestani - Lund university, Lund, Sweden )

Micro-ultrasound is as effective as MRI in detecting prostate cancer

Dr Laurence Klotz - Sunnybrook Health Sciences Centre, Toronto, Canada

Micro-ultrasound is as effective as MRI in detecting prostate cancer ( Dr Laurence Klotz - Sunnybrook Health Sciences Centre, Toronto, Canada )

Bone-protective agents given with enzalutamide with or without radium-223 show...

Prof Fred Saad - University of Montreal Hospital Center, Montreal, Canada

Bone-protective agents given with enzalutamide with or without radium-223 show greater survival benefits in mCRPC ( Prof Fred Saad - University of Montreal Hospital Center, Montreal, Canada )

Darolutamide plus ADT provides deep and durable PSA responses in metastatic...

Prof Fred Saad - University of Montreal Hospital Center, Montreal, Canada

Darolutamide plus ADT provides deep and durable PSA responses in metastatic hormone-sensitive prostate cancer ( Prof Fred Saad - University of Montreal Hospital Center, Montreal, Canada )

Transperineal biopsy improves prostate cancer detection

Prof Richard Bryant - Churchill Hospital in Oxford, Oxford, UK

Transperineal biopsy improves prostate cancer detection ( Prof Richard Bryant - Churchill Hospital in Oxford, Oxford, UK )

Adjuvant docetaxel shows no significant advantage compared to surveillance in...

Dr Pirkko-Liisa Kellokumpu-Lehtinen - Tampere University Hospital, Tampere...

Adjuvant docetaxel shows no significant advantage compared to surveillance in high-risk prostate cancer after 10 years ( Dr Pirkko-Liisa Kellokumpu-Lehtinen - Tampere University Hospital, Tampere, Finland )

TAR-200 plus cetrelimab show encouraging outcomes for MIBC patients ineligible...

Dr Sarah Psutka - University of Washington, Seattle, USA

TAR-200 plus cetrelimab show encouraging outcomes for MIBC patients ineligible for standard cisplatin-based chemotherapy ( Dr Sarah Psutka - University of Washington, Seattle, USA )

More from ecancer